Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Archary, D.
- Contributor
-
Rong, R.
Gordon, ML
Boliar, S.
Gray, ES
Dugast, A.
Hermanus, T.
Goulder, PJ
Coovadia, HM
Morris, L.
Alter, G.
Derdeyn, CA
Ndung'u, T.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P75
- URN
-
urn:nbn:de:1111-2016080728575
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Archary, D.
- Rong, R.
- Gordon, ML
- Boliar, S.
- Gray, ES
- Dugast, A.
- Hermanus, T.
- Goulder, PJ
- Coovadia, HM
- Morris, L.
- Alter, G.
- Derdeyn, CA
- Ndung'u, T.
- SpringerLink (Online service)
Other Objects (12)
Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Broadly Neutralizing Antibodies for HIV Eradication
P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine
HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
Circulating CXCR3+ Tfh cells positively correlate with neutralizing antibody responses in HCV-infected patients
Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Broadly Neutralizing Antibodies for HIV Eradication
P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine
HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
Circulating CXCR3+ Tfh cells positively correlate with neutralizing antibody responses in HCV-infected patients
Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
Neutralizing antibodies in humans infected with zoonotic simian foamy viruses
Cross-reactive neutralizing activity in HIV-1 infected injecting drug users
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Broadly Neutralizing Antibodies for HIV Eradication
P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine
HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection